Roles of SIRT1 in High Glucose-induced Endothelial Impairment: Association with Diabetic Atherosclerosis

Archives of Medical Research

Volumn 42, Issue 5, 2011, Pages 354-360

  Yang, Juhong ^a   Wang, Nan ^a   Zhu, Yu ^a   Feng, Ping ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; E selectin; Endothelial cells; Endothelial nitric oxide synthase; Nitric oxide; Resveratrol; SIRT1; Type 2 diabetes mellitus

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; MESSENGER RNA; NITRIC OXIDE; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION; WESTERN BLOTTING;

ATHEROSCLEROSIS; BASE SEQUENCE; CELLS, CULTURED; DIABETIC ANGIOPATHIES; DNA PRIMERS; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; NITRIC OXIDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIRTUIN 1; STILBENES;

EID: 80052741274     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.07.005     Document Type: Article

References (28)

1. James P.T., Rigby N., Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004, 11:3-8.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
3. Fontana L., Meyer T.E., Klein S., et al. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA 2004, 101:6659-6663.
4. Cohen H.Y., Miller C., Bitterman K.J., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 16:390-392.
5. Mattagajasingh I., Kim C.S., Naqvi A., et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007, 104:14855-14860.
6. Ota H., Akishita M., Eto M., et al. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007, 43:571-579.
7. Zhang Q.J., Wang Z., Chen H.Z., et al. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 2008, 80:191-199.
8. Milne J.C., Lambert P.D., Schenk S., et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 450:712-716.
9. Picard F., Kurtev M., Chung N., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429:771-776.
10. Fontana L., Meyer T.E., Klein S., et al. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA 2004, 101:6659-6663.
11. Fontana L., Klein S., Holloszy J.O., et al. Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. J Clin Endocrinol Metab 2006, 91:3232-3235.
12. Meyer T.E., Kovács S.J., Ehsani A.A., et al. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol 2006, 47:398-402.
13. Heilbronn L.K., de Jonge L., Frisard M.I., et al. Pennington CALERIE Team. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 2006, 295:1539-1548.
14. Qiao L., Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem 2006, 281:39915-39924.
15. Pedersen S.B., Ølholm J., Paulsen S.K., et al. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int J Obes (Lond) 2008, 32:1250-1255.
16. Cardellini M., Menghini R., Martelli E., et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 2009, 58:2396-2401.
17. Napoli C., de Nigris F., Williams-Ignarro S., et al. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006, 15:265-279.
18. Barbato J.E., Tzeng E. Nitric oxide and arterial disease. J Vasc Surg 2004, 40:187-193.
19. Anderson T.J. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fair Rev 2003, 8:71-86.
20. Santilli F., Cipollone F., Mezzetti A., et al. The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 2004, 36:319-335.
21. Nisoli E., Tonello C., Cardile A., et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310:314-317.
22. Blann A.D., Lip G.Y. McCollum CN. Changes in von Willebrand factor and soluble ICAM, but not soluble VCAM, soluble E selectin or soluble thrombomodulin, reflect the natural history of the progression of atherosclerosis. Atherosclerosis 2002, 165:389-391.
23. Nasuno A., Matsubara T., Hori T., et al. Levels of soluble E-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: association with the severity of coronary atherosclerosis. Jpn Heart J 2002, 43:93-101.
24. Wojakowski W., Gminski J. Soluble ICAM-1, VCAM-1 and E-selectin in children from families with high risk of atherosclerosis. Int J Mol Med 2001, 7:181-185.
25. Morigi M., Angioletti S., Imberti B., et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998, 101:1905-1915.
26. Yeung F., Hoberg J.E., Ramsey C.S., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
27. Stein S., Lohmann C., Schäfer N., et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 2010, 31:2301-2309.
28. Menghini R., Casagrande V., Cardellini M., et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.